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With over two-thirds of women in the United States receiving neuraxial analgesia or 
anesthesia to ease the pain of labor and delivery, advances in epidural technology can potentially 
influence the childbirth experience. Continuous epidural infusion (CEI) with patient-controlled 
epidural analgesia (PCEA) has been the mainstay for delivering epidural labor analgesia for the 
past two decades; however, programmed intermittent epidural bolus (PIEB) is making its debut 
as a promising new technology to improve labor analgesia. Literature suggests delivery of 
programmed boluses of dilute local anesthetic with or without opioid at regularly spaced 
intervals may result in lower local anesthetic utilization while maintaining or improving 
analgesia quality and maternal satisfaction and minimizing motor blockade.  
The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to develop 
and plan for translation of an evidence-based clinical practice protocol for PIEB for labor 
analgesia in a critical access hospital. The clinical practice protocol incorporated findings from 
an integrated literature review. Planning for implementation of the clinical practice protocol 
consisted of a before-and-after without control design to measure the effect of PIEB with PCEA 
modality for labor analgesia (after group) on analgesia quality, local anesthetic utilization, and 
prevalence of motor blockade compared to the CEI with PCEA modality (before group). The 
plan for translation includes the provision of staff education about protocol implementation. 
iv 
Lastly, structure, process, outcomes, and balancing measures were identified to evaluate 
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Pain during labor is a nearly universal phenomenon that warrants consideration during a 
woman’s childbirth experience. Various therapies have been employed to ease labor pain, with 
epidural analgesia ranking as not only the most widely used pharmacologic technique (Schrock 
& Harraway-Smith, 2012), but also the modality with the most effective analgesia for labor pain 
(Capogna et al., 2011). Not surprisingly, the epidural rate in U.S. obstetric patients increased by 
10% from 2008 to 2014, with 71% of pregnant women receiving neuraxial analgesia or 
anesthesia (Butwick et al., 2018). These statistics emphasize the merit of providing effective 
epidural analgesia focused on improving the quality of analgesia while simultaneously 
decreasing the degree of motor blockade.  
Utilization of programmed intermittent epidural bolus (PIEB) shows promise as a 
technique theorized to improve the spread of epidural medication compared to continuous 
infusion, despite using the same hourly volume of solution (Hogan, 2002; Kaynar & Shankar, 
1999), thus hypothetically leading to less local anesthetic consumption for similar or improved 
quality of analgesia. The implications for clinical practice are varied and may include shorter 
duration of the second stage of labor, higher maternal satisfaction, reduction in instrumented 
delivery rates, and less need for clinician intervention for breakthrough pain (George et al., 




laboring mothers (Tien et al., 2016); fortunately, epidural pumps with advanced technology that 
allows programmable intermittent dosing are becoming more mainstream, allowing translation of 
evidence into practice to be carried out more readily. As more advanced epidural pumps become 
available, studies on the optimal epidural solution, bolus dose, and interval timing are up-and-
coming (Delgado et al., 2018; Epsztein Kanczuk et al., 2017; Zakus et al., 2018).  
Background 
In the setting of neuraxial techniques for labor analgesia, the primary goal is to provide 
adequate pain relief while preserving motor function (American Association of Nurse 
Anesthetists [AANA], 2017). Epidural analgesia is achieved with administration of low 
concentrations of local anesthetics (e.g., bupivacaine or ropivacaine) with or without opioids 
(e.g., fentanyl or sufentanil), which permits lower doses of each agent and mitigates adverse side 
effects. Epidural analgesia for labor is typically initiated using epidural or combined-spinal 
epidural (CSE) technique, followed by infusion of a local anesthetic solution via an epidural 
catheter, oftentimes using a continuous epidural infusion (CEI) with or without patient-controlled 
epidural analgesia (PCEA).  
Gambling et al. (1988) conducted a randomized controlled trial comparing the efficacy of 
PCEA alone with CEI and found that laboring patients in the PCEA group used significantly less 
mean hourly bupivacaine (M = 0.85 mg/hr, SD = 11.2 mg vs. M = 0.5 mg/hr, SD = 15.2 mg, p < 
.01), but had no significant differences in degree of analgesia. In another study, Paech (1992) 
was the first to investigate the effects of administering PCEA in addition to CEI for labor 
analgesia. Fifty-two laboring mothers were randomized to receive either PCEA alone or PCEA 
with CEI of 4 ml/hr of 0.125% bupivacaine plus fentanyl 3 μg/ml. Though the study did not 
demonstrate a statistically significant difference in pain relief, supplementary boluses, or 
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maternal satisfaction, it did serve as a springboard for further trials investigating the effects of 
different background infusion rates (most ranging from 2-10 ml/hr), local anesthetics, drug 
concentrations, and PCEA bolus volume and lockout intervals. Both of these initial studies 
represent a pivotal turning point in favor of bolus-based epidural analgesia, which spurred many 
more studies, and ultimately led to CEI with PCEA becoming arguably the reference standard for 
labor epidural analgesia (Halpern & Carvalho, 2009; Onuoha, 2017; Sng et al., 2015).  
In a systematic review by Halpern and Carvalho (2009), PCEA added to a background 
infusion improved the quality of analgesia by reducing breakthrough pain and clinician 
interventions. Halpern and Carvalho’s review (2009) included randomized controlled trials that 
compared PCEA use of the following categories: background infusion versus no background 
infusion, ropivacaine versus bupivacaine, and high-volume PCEA bolus versus low-volume 
PCEA bolus and/or longer lockout interval versus shorter lockout interval. Studies comparing 
background infusions versus no background infusions found that background infusions reduced 
the need for clinician intervention for breakthrough pain and may have improved analgesia. 
Moreover, several trials included in the review compared ropivacaine to bupivacaine. Halpern 
and Carvalho (2009) concluded that ropivacaine and bupivacaine for PCEA boluses are 
appropriate for use in labor patients; however, they reported increased incidence of motor 
blockade with bupivacaine use. Motor blockade was especially evident at increased local 
anesthetic concentrations (e.g., bupivacaine 0.25% or greater, ropivacaine 0.2% or greater). 
Interestingly, one study found that the ED50 of bupivacaine for initiation of epidural analgesia for 
labor was lower when 0.125% bupivacaine was used compared to 0.25% bupivacaine (Lyons et 
al., 2007). The postulated rationale for this finding is that the use of more dilute local anesthetic 
solutions results in increased volume injected into the epidural space, possibly resulting in more 
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uniform spread in the epidural space (Hogan, 2002). Bolus dose volume and lockout intervals 
were also reviewed. While various regimens produced effective analgesia, evidence of the ideal 
dose volume and lockout interval was limited. It was suggested that larger boluses (e.g., 10-12 
ml) of dilute local anesthetic provide superior analgesia than smaller boluses (e.g., 4-5 ml) in the 
absence of a background infusion. Shorter lockout intervals (e.g., 5-8 min) were found to 
improve the PCEA given:attempted ratio, but this did not reflect better analgesia or improved 
maternal satisfaction. 
While CEI with PCEA is a widely popular modality for delivering epidural analgesia 
during labor, it is not without limitations. In a meta-analysis of ropivacaine and fentanyl epidural 
analgesia, the incidence of motor blockade was found to be 18.28% for continuous infusions 
(Zhang et al., 2018). Motor blockade significantly correlated with instrumental vaginal delivery 
(r = .64, p = .0001) (Zhang et al., 2018). The duration of the second stage of labor was also 
positively associated with the incidence of motor blockade (OR 0.23 [95% CI 0.01, 0.44], p = 
.043) (Zhang et al., 2018). Though there was no significant correlation between the incidence of 
motor blockade and cesarean delivery (r = .18, p = .309), percent fentanyl concentration and total 
fentanyl dosage positively correlated with incidence of cesarean delivery (percent fentanyl 
concentration b = 25,358, p = .003; total fentanyl dosage r = .45, p = .046). Conversely, fentanyl 
concentration and total fentanyl dosage was negatively associated with the incidence of 
instrumental deliveries (percent fentanyl concentration b = -36,809, p = .015; total fentanyl 
dosage r = -.48, p = .046).   
In an effort to improve labor analgesia and minimize side effects, namely motor 
blockade, PIEB regimens have been developed. The use of PIEB settings was conceived based 
largely on cadaveric and experimental studies on the improved spread of liquids within the 
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epidural space with bolus delivery (Hogan, 2002; Kaynar & Shankar, 1999) and previous studies 
on manual bolus delivery by the clinician (Bogod et al., 1987; Boutros et al., 1999; Smedstad & 
Morison, 1988). Studies on the efficacy of single-orifice versus multiorifice epidural catheters 
are mixed, for which Kaynar and Shankar (1999) attributed to differential flow through the 
multiorifice catheter. Flow is greatest at the proximal hole, which under low injection pressures, 
such as with CEI, the catheter essentially acts as single-orifice with no flow observed through the 
distal ports. Kaynar and Shankar (1999) conducted a study to observe the difference in diffusion 
of a contrast solution from a multiorifice catheter during continuous infusion (10 ml/hr) or 
intermittent bolus (3.5 ml boluses over 1 minute every 20 minutes). They found that the 
continuous infusion flowed mainly through the proximal hole with practically no flow through 
the distal hole. Conversely, flow from the intermittent boluses was observed through all holes. 
This resulted in a wider spread of contrast solution in the intermittent bolus compared to 
continuous infusion (1.4 vs 0.26 in2) (Kaynar & Shankar, 1999).  
Statement of the Problem 
 The premise of the provision of epidural analgesia for labor is adequate pain relief while 
supporting maternal and neonatal outcomes. Programmed intermittent epidural bolus modality of 
analgesia has been shown to improve quality of analgesia, decrease local anesthetic 
consumption, and improve maternal satisfaction compared to CEI mode of delivery (Sng et al., 
2018); however, CEI with PCEA remains a prevalent mode of delivery and was the existing 
practice at the critical access hospital that was the target of this Doctor of Nursing Practice 
(DNP) scholarly project. In response to this problem, this project proposed to develop a clinical 
practice protocol for PIEB for labor and plan for implementation and evaluation of the protocol 
in a critical access hospital.   
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Purpose of the Project 
The purpose of this DNP scholarly project was to develop, implement, and evaluate an 
evidence-based clinical practice protocol for PIEB for labor analgesia in a critical access 
hospital. The project focused on enhancing labor analgesia outcomes by providing stakeholders 
with an evidence-based clinical practice protocol used to implement the practice change from 
CEI to PIEB for labor analgesia. 
Need for the Project 
While studies on the superiority of PIEB compared to CEI are emerging, widespread 
adoption of PIEB in clinical practice has been limited by the unavailability of epidural pumps 
with advanced technology capable of PIEB dosing (Tien et al., 2016). As more advanced 
epidural pumps become available, studies on the optimal epidural solution, bolus dose, and 
interval timing are transpiring. Considering these studies, the need for translation of the evidence 
to interventions aimed at improving labor epidural analgesia outcomes was evident in this DNP 
scholarly project.  
Study Questions 
 This project aimed to answer the following population, intervention, comparison, 
outcome, and time (PICOT) questions:  
Q1 In healthy laboring women in a critical access hospital (patient population) how 
effective is PIEB with PCEA settings for labor epidural analgesia (intervention of 
interest) compared to CEI with PCEA (comparison intervention) on quality of 
analgesia (outcome) during labor and delivery (time)? Quality of analgesia is 
measured by: (a) visual analog scale (VAS), visual numeric pain score (VNPS), or 
verbal rating scale (VRS) 30 min after epidural placement and hourly thereafter 
until delivery by the patient; (b) PCEA given: attempted ratio; (c) time (min) to first 
PCEA use; (d) time (min) to first certified registered nurse anesthetist (CRNA) 
intervention (manual bolus of additional epidural medication, adjustments in pump 
settings, or manipulation of the epidural catheter); and (e) number of top-up doses 




Q2 In healthy laboring women in a critical access hospital (patient population) how 
effective is PIEB with PCEA settings for labor epidural analgesia (intervention of 
interest) compared to CEI with PCEA (comparison intervention) on incidence of 
motor blockade (outcome) as measured 30 min after epidural placement and hourly 
thereafter until delivery (time)? Motor blockade is measured by Bromage scale.  
 
Q3 In healthy laboring women in a critical access hospital (patient population) how 
effective is PIEB with PCEA settings for labor epidural analgesia (intervention of 
interest) compared to CEI with PCEA (comparison intervention) on hourly and total 
local anesthetic utilization (outcome) during labor and delivery (time)?  
 
Objectives of the Project 
 The objectives of the project are outlined here. Objectives were to: 
1.  Collect and analyze data and outcome measures (e.g., demographics/maternal 
characteristics, obstetrical data, analgesia quality, motor blockade, and local 
anesthetic utilization) and baseline maternal satisfaction scores and untoward epidural 
complications (e.g., high block level, unilateral block, “hot spot,” catheter migration, 
hypotension requiring intervention, pruritis requiring intervention, nausea/vomiting 
requiring intervention, etc.) of the existing practice of CEI with PCEA modality of 
labor analgesia. 
2. Develop a clinical practice protocol for PIEB with PCEA modality of labor epidural 
analgesia based on synthesis of the existing body of literature. 
3. Translate the clinical practice protocol for PIEB with PCEA modality of labor 
epidural analgesia into practice.  
4. Evaluate the practice change in terms of: (a) structure measures (i.e., adequate 
resources); (b) process measures (i.e., measure of fidelity to the protocol); (c) 
outcome measures (e.g., demographics/maternal characteristics, analgesia quality, 
local anesthetic utilization, and motor blockade, and obstetrical data); and (d) 
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balancing measures (e.g., maternal satisfaction scores and untoward epidural 
complications). 
Definitions of Terms 
Breakthrough pain: pain requiring intervention from the CRNA, such as manual bolus of 
additional epidural medication, adjustments in pump settings, or manipulation of the 
epidural catheter. 
Combined-spinal epidural (CSE): a neuraxial technique that employs injection of medication 
into the intrathecal space, followed by insertion of a catheter into the epidural space for 
continued analgesia. 
Continuous epidural infusion (CEI): infusion modality for delivery of medication to the 
epidural space via catheter at a constant, or basal, rate; may be combined with PCEA 
setting. 
Epidural analgesia: a neuraxial technique of introducing an analgesic agent into the epidural 
space (includes both epidural and CSE techniques). 
First stage of labor: stage of labor that begins with onset of labor and ends when cervix is 100% 
effaced and fully dilated to 10cm. 
Local anesthetic utilization: combined hourly use of pump delivered (calculated via the pump 
totals) and CRNA-delivered local anesthetic medications (calculated via documentation 
in the anesthesia record). 
Motor blockade: lower limb motor weakness indicated by Bromage scale grade II-IV. 
Patient controlled epidural analgesia (PCEA): an additional top-up dose of supplementary 
analgesia dose by patient activation of a programmable pump. 
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Programmed intermittent epidural bolus (PIEB): infusion modality for delivery of 
medication to the epidural space via catheter an intermittent dose (every now and again); 
may be combined with PCEA setting. 
Second stage of labor: stage of labor that begins when cervix is completely effaced and dilated 
and ends with delivery of the baby. 













REVIEW OF THE LITERATURE 
 
 
 In this chapter, the literature review describes the historical background of the problem. 
Multiple studies are discussed showing the superiority of PIEB compared to CEI with PCEA 
regimens for maintenance of labor analgesia. Studies examining various epidural solutions and 
optimal PIEB pump settings are reviewed for their relevance to implementation in a critical 
access hospital. Stetler’s model of research utilization and Donabedian’s model are also 
discussed as the theoretical frameworks that underpin the scholarly project.  
Historical Background 
Neuraxial anesthesia was first described in 1885 by Leonard James Corning, an 
American neurologist who initially experimented with spinal anesthesia using cocaine in dogs 
and later in human subjects (Corning, 1885). Not long after in 1900, Oskar Kreis, a Swiss 
obstetrician, pioneered the first use of spinal cocaine in six parturients for labor pain (Schneider 
& Holzgreve, 2001). An early case report using spinal anesthesia with cocaine for cesarean 
section discussed the perceived benefit of maintained uterine tone during spinal anesthesia versus 
ether or chloroform anesthesia (Hopkins, 1902). Unfortunately, rare but serious complications of 
spinal anesthesia (e.g., high spinal, neurologic injuries, and death) were reported and resulted in 
a decline in its use for a short period of time (“Spinal Anesthesia,” 1909). Single-shot caudal 
epidural techniques were also described in 1909 by German obstetrician Stoeckel in a case series 
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of 141 obstetric patients. It was not until 1931 that a technique for continuous caudal epidural 
was described by Eugen Aburel (Chau & Tsen, 2018). Several pivotal advances for epidural 
analgesia occurred over the next several decades until the 1980s when epidural analgesia became 
widely available (Meng & Smiley, 2017). Historically, epidural analgesia was achieved with an 
initial loading dose of local anesthetic and maintained by manual boluses by the provider (Chau 
& Tsen, 2018). Continuous epidural infusions with PCEA became mainstream with the advent of 
electronic pumps (Chau & Tsen, 2018). Intermittent bolus methods have also been described, 
with Kaynar and Shankar (1999) first describing improved spread and block quality with 
intermittent boluses versus continuous infusions.  
Literature Review 
Methodology 
The literature on PIEB for labor analgesia was searched via PubMed (Medline), 
Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials 
(CENTRAL), and the Cumulative Index of Nursing and Allied Health Literature (CINAHL). 
References within eligible articles were also screened for additional sources. The search was 
conducted September through March 2019. The Boolean operator “AND” was used to combine 
search terms “programmed intermittent epidural bolus” or “automated intermittent epidural 
bolus,” and “labor.” Results of the search query were further refined to full-text scholarly journal 
articles in the English language. Studies including non-obstetric patient populations were 
excluded. Titles and abstracts were reviewed to determine relevance, including exclusion of 
studies that were not specific to the PIEB method and exclusion of reviews, editorials, and 
clinical updates.  
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In total, 22 studies were deemed relevant to the research question and compiled for 
analysis and synthesis, including 13 randomized controlled trials (Capogna et al., 2011; Ferrer et 
al., 2017; Fettes et al., 2006; Lange et al., 2018; Leo et al., 2010; Lin et al., 2016; Nunes et al., 
2016; Patkar et al., 2015; Rodriguez-Campoo et al., 2018; Sia et al., 2013, 2007; Wong et al., 
2011, 2006), 2 biased coin up-and-down sequential allocation trials (Epsztein Kanczuk et al., 
2017; Zakus et al., 2018), 3 systematic reviews (George et al., 2013; Sng et al., 2018; Xu et al., 
2019), 2 prospective controlled before-and-after cohort studies (Bullingham et al., 2018; Delgado 
et al., 2018), and 2 retrospective studies (McKenzie et al., 2016; Tien et al., 2016).  
Synthesis 
Overall  
Fifteen of the 22 studies compared CEI with or without PCEA to PIEB with or without 
PCEA. Of those studies, 11 used randomized controlled trial design (Capogna et al., 2011; Ferrer 
et al., 2017; Fettes et al., 2006; Leo et al., 2010; Lin et al., 2016; Nunes et al., 2016; Patkar et al., 
2015; Rodriguez-Campoo et al., 2018; Sia et al., 2013, 2007; Wong et al., 2006), 2 used 
prospective before-and-after cohort design (Bullingham et al., 2018; Delgado et al., 2018), and 2 
used retrospective designs (McKenzie et al., 2016; Tien et al., 2016). Most of these used the 
same epidural solution for the CEI group and PIEB groups, except for the Bullingham et al. 
(2018) and Nunes et al. (2016) studies, both of which utilized a more dilute concentration of 
local anesthetic for the PIEB groups. Several studies compared various PIEB settings without a 
CEI comparison group (Delgado et al., 2018; Epsztein Kanczuk et al., 2017; Lange et al., 2018; 
Tien et al., 2016; Wong et al., 2011; Zakus et al., 2018). Three systematic reviews are also 
included in the synthesis (George et al., 2013; Sng et al., 2018; Xu et al., 2019).  
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The measurement outcomes of each study varied, but could be broadly categorized as 
quality and efficacy of analgesia, local anesthetic consumption, motor blockade, maternal 
outcomes, and neonatal outcomes. Several studies found significant differences in the presence 
of motor blockade among women who received PIEB compared to CEI (Bullingham et al., 2018; 
Epsztein Kanczuk et al., 2017). Using the Bromage scale for assessment of lower limb motor 
blockade, Bullingham et al. (2018) found that 21.8% of women in the CEI group experienced 
some degree of motor blockade (Bromage score II-IV) versus only 1.0% of women in the PIEB 
with PCEA group (p < .001). Similarly, in another study comparing the time interval in minutes 
between PIEB of 10 ml of 0.0625% bupivacaine with fentanyl 2 μg/ml, only 15.4% of women in 
the 30-minute interval group experienced motor blockade (Bromage II-IV) compared to none in 
the 40-, 50-, and 60-minute interval groups (Epsztein Kanczuk et al., 2017).  
Chen and colleagues (2014) suggested that the presence of motor blockade in nulliparous 
women receiving CEI analgesia may affect the duration and effectiveness of expulsive efforts in 
the second stage of labor and, therefore, increases the rates of instrumented delivery, although a 
systematic review of 11 studies with a total of 1,079 women participants found little or no 
difference in PIEB compared to CEI in the risk of instrumented delivery (12% and 9%, 
respectively; RR 0.75, 95% CI [0.54, 1.06]) nor in the mean difference in duration of labor (MD 
= -10.38 min, 95% CI [-26.73, 5.96]) (Sng et al., 2018). Somewhat contrary to these findings, 
Bullingham et al. (2018) found the duration of the second stage of labor to be significantly 
shorter in PIEB groups compared to CEI groups of nulliparous women (M = 79.4 min, SD = 55.1 
vs. M = 108.2 min, SD = 61.2, p < .002); however, no significant difference was found in PIEB 
versus CEI groups among multiparous women (M = 45.1 min, SD = 52.1 vs. M = 52.8 min, SD = 
52.3, p = .510).  
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Likely related to the decreased prevalence of motor blockade, several studies have shown 
decreased local anesthetic consumption in PIEB groups compared to CEI groups (Bullingham et 
al., 2018; Ferrer et al., 2017; Sng et al., 2018). In one study, hourly ropivacaine consumption in 
the PIEB group was significantly less than the CEI group (M = 7.8 mg, SD = 0.44 vs. M = 13.8 
mg, SD = 0.89, p < .001) (Bullingham et al., 2018). However, the study used a lower 
concentration of ropivacaine for the PIEB group than for the CEI group, so the results may be 
skewed. Ferrer et al. (2017) also showed a decreased utilization of local anesthetic, albeit 
bupivacaine, with the PIEB group consuming a total drug dose of 24.9 mg (SD = 13.5, 95% CI 
[21.5, 28.3]) compared to the CEI group consumption of 34.4 mg (SD = 21.4, 95% CI [29.0, 
39.7], p = .13). Similarly, a systematic review of 12 studies of 1,121 women suggested a 
reduction in total hourly consumption of local anesthetic with PIEB compared to CEI (MD = -
1.08 mg/hr, 95% CI [-1.78, -0.38]) (Sng et al., 2018). Improved analgesia quality as evidenced 
by a decrease in the number of women requiring either manual top-up boluses or PCEA boluses 
for breakthrough pain was also demonstrated in several studies (Delgado et al., 2018; Epsztein 
Kanczuk et al., 2017; Ferrer et al., 2017). Furthermore, in a systematic review including seven 
studies of 570 women evaluating maternal satisfaction of labor epidural analgesia, five studies 
reported an increase in the PIEB groups compared to the CEI groups (Sng et al., 2018).  
Local Anesthetic and Opioid  
Adjuncts  
Various local anesthetic solutions were used, including bupivacaine with fentanyl or 
sufentanil (Delgado et al. 2018; Epsztein Kanczuk et al., 2017; Ferrer et al., 2017; Lange et al., 
2018; McKenzie et al., 2016; Tien et al., 2016; Wong et al., 2011, 2006; Zakus et al., 2018), 
ropivacaine with fentanyl or sufentanil (Bullingham et al., 2018; Fettes et al., 2006; Leo et al., 
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2010; Lin et al., 2016; Nunes et al., 2016; Patkar et al., 2015; Sia et al., 2013, 2007), and 
levobupivacaine with sufentanil (Capogna et al., 2011; Rodriguez-Campoo et al., 2018).  
 Bupivacaine. Bupivacaine concentrations ranged from 0.0125% (Tien et al., 2016) to 
bupivacaine 0.1% (Ferrer et al., 2017), with the majority using 0.0625% bupivacaine. Of the 
studies using bupivacaine solutions, all but one included fentanyl ranging from 1.95-2 μg/ml. 
The study that did not use fentanyl used sufentanil 0.4 μg/ml (McKenzie et al., 2016). 
 Ropivacaine. Ropivacaine concentrations ranged from 0.1% (Bullingham et al., 2018; 
Leo et al., 2010; Lin et al., 2016; Nunes et al., 2016; Patkar et al., 2015; Sia et al., 2013, 2007) to 
0.2% (Bullingham et al., 2018; Fettes et al., 2006). Of the studies using ropivacaine solutions, six 
included fentanyl 2 μg/ml (Bullingham et al., 2018; Fettes et al., 2006; Leo et al., 2010; Patkar et 
al., 2015; Sia et al., 2013, 2007), and two included sufentanil ranging from 0.2 μg/ml (Nunes et 
al., 2016) to 0.3 μg/ml (Lin et al., 2016). 
 Levobupivacaine. Only two studies used a levobupivacaine solution, with the CEI and 
PIEB maintenance infusion concentrations of 0.0625% (Capogna et al., 2011; Rodriguez-
Campoo et al., 2018). One study included sufentanil 0.5 μg/ml and PCEA boluses of 0.125% 
levobupivacaine with sufentanil 0.5 μ/ml (Capogna et al., 2011). One study included fentanyl 1 
μg/ml (Rodriguez-Campoo et al., 2018).  
Epidural Pump Settings  
Programmed bolus volumes and time intervals varied among studies. Most studies 
utilized a PIEB setting of 10 ml every 1 hour with PCEA or provider-dosed boluses for 
breakthrough pain. Several studies aimed to determine optimal PIEB settings. Wong et al. (2011) 
compared three bolus regimens: 2.5 ml every 15 minutes, 5 ml every 30 minutes, and 10 ml 
every 60 minutes. Breakthrough pain was treated with PCEA, followed by manual boluses if 
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needed. The 10 ml every 60 minutes group decreased bupivacaine consumption most without 
decreasing patient comfort or satisfaction. While most studies employed a PCEA setting or 
clinician-delivery bolus for breakthrough pain, Epsztein Kanczuk et al. (2017) aimed to 
determine the optimal time interval between PIEB of 10 ml of bupivacaine 0.0625% with 
fentanyl 2 μg/ml. Using biased coin up-down sequential allocation, they found that the optimal 
time interval was approximately 40 minutes (Epsztein Kanczuk et al., 2017). With this evidence 
on the optimal time interval, Zakus et al. (2018) sought to determine the optimal PIEB volume at 
a fixed interval of 40 minutes. The findings suggested that reduction in volume (i.e., less than 10 
ml) was not possible without compromising quality of analgesia. Another study compared the 
effect of PIEB rate of infusion on labor analgesia quality (Lange et al., 2018). Patients were 
assigned to either high-rate bolus over 2 minutes, or low-rate bolus over 6 minutes. Patient 
outcomes did not differ with high- versus low-rate bolusing.   
Theoretical Frameworks 
Stetler’s Model of Research  
Utilization 
The Stetler model of research utilization was first developed by Stetler and Marram in 
1976. The model was further refined in 1994 and again in 2001 to incorporate emerging trends in 
evidence-based practice. The primary focus of the Stetler model is utilization of research 
findings in individual practice or by individuals operating within a group under the premise that 
critical thinking plays a key role in facilitating safe and effective use of research findings 
(Stetler, 2001). The model has five phases: preparation, validation, comparative 
evaluation/decision making, translation/application, and evaluation.  
The preparation phase requires the user to clarify the purpose of the research utilization. 
This phase seeks to answer “why” the research utilization is needed in nursing practice. The 
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potential significance of influential internal (e.g., personal factors that diminish objectivity) or 
external factors (e.g., politics, imposed deadlines, or prioritized goals of the organization) is also 
considered (Stetler, 2001). Measurable outcomes might also be identifiable. Additionally, the 
user is directed to differentiate sources of relevant research evidence in their literature search and 
select studies appropriate to the purpose of the research utilization.  
In this DNP scholarly project, the preparation phase began with defining the purpose, 
which was to incorporate the most up-to-date evidence about labor epidural analgesia into 
practice. Influential factors included the organization’s commitment to cost-effective care, 
patient satisfaction initiatives, as well as the author’s own biases about the appeal of new 
interventions. Relevant evidence from the literature was limited to quantitative studies. 
Measurable outcomes included pain scores, interventions for break-through pain, amount of local 
anesthetic used, and motor blockade. 
The second phase is validation, which involves a utilization-focused critique of the 
evidence. This involves appraisal of the findings of the study, rather than simply appraisal of the 
study itself. The process of critiquing and recording each study involves documentation in both a 
methodological table and a utilization table (Stetler et al., 1998). The process ends here if there is 
insufficient evidence. If the evidence is deemed sufficient, progression to the comparative 
evaluation/decision-making phase ensues where synthesis of the evidence occurs. This phase has 
four criteria that are used to determine application of the study’s finding to practice. The four 
criteria are fit of setting, feasibility (risk factor, resources, and readiness), current practice, and 
substantiating evidence. On the basis of the synthesis and the applicability criteria, a decision to 
use, not use, or consider use is made. To use means to accept and use the findings immediately. 
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To not use means to reject the findings altogether. To consider use means a delay in use, pending 
further information.  
For this DNP scholarly project, an integrative review process was used to systematically 
analyze and synthesize findings from research to facilitate decision making regarding protocol 
recommendations for the practice change. The integrative review process was adapted from 
Stetler et al.’s (1998) integrative review framework and incorporated the following steps:  
1. Form an integrative review group. 
2. Outline the problem and review process. 
3. Select and evaluate applicable studies, and synthesize findings.  
4. Develop recommendations based on synthesis.  
5. Disseminate recommendations to the integrative review group for approval.  
During synthesis of the findings, the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) 
Rating Scale was used to evaluate the strength and quality of the evidence (Dang & Dearholt, 
2017).  
At this point, the level of application (e.g., individual, group, or organization) needs to be 
made in order to develop a proposal for practice change. Translation/application is the “how-to” 
phase of implementation of the evidence from the previous phases. If use goes beyond simple 
informal use, strategies for formal dissemination and evidence-based change plans are 
developed. For this DNP scholarly project, the translation/application phase involved key 
stakeholders, such as fellow CRNAs, obstetric providers, nursing staff, pharmacists, and patients. 
A clinical practice protocol was developed based on the integrative review. Education on 
protocol implementation, including pump setup for PIEB settings, was developed as part of the 
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translation plan. A data collection worksheet was used to collect baseline and can be used to 
collect post-implementation data. 
Evaluation is the fifth and final phase of the Stetler model. Evaluation can be formal or 
informal. In this case, a high degree of rigor is appropriate because the DNP scholarly project 
involved pre- and post-intervention comparisons of measures. Stetler (2001) recommended using 
both formative and summative evaluation of outcomes in order to evaluate if implementation is 
going as planned and outcome or goal achievement.  
Donabedian’s Model  
Donabedian (2005) is credited as a pioneer in healthcare quality and safety. He proposed 
that the quality of healthcare can be measured using a 3-prong approach focused on the 
relationship between structure, process, and outcome within an organization. Balancing measures 
are also considered alongside contemporary descriptions of the Donabedian model (Fondahn et 
al., 2016). Measures for structure, process, and outcome are components for evaluation of the 
degree to which an improvement project results in the desired impact. For this DNP scholarly 
project, structure measures included the resources available to provide adequate patient care, 
such as epidural pumps with advanced technology, the presence of competent staff members, 
staff education resources, and administrative support. Process measures reflect the degree to 
which the protocol is being followed. Outcome measures determine if the practice change project 
had the desired outcome of improving the quality of labor epidural analgesia. Lastly, balancing 
measures evaluated if improvements gained from the practice change negatively impacted 















 This chapter details the methods used for the DNP scholarly project. The design of the 
project, the setting and sample, and the measures used are described. Plans for data analysis are 
presented along with limitations of the project. The informed consent process and the protection 
of human subjects are detailed.  
Design 
 The DNP scholarly project included development of an evidence-based clinical practice 
protocol incorporating findings from an integrated literature review. Implementation of a before-
and-after without control design was planned in collaboration with a multidisciplinary team to 
measure the effect of PIEB with PCEA modality for labor analgesia (after group) on analgesia 
quality, local anesthetic utilization, and prevalence of motor blockade compared to the CEI with 
PCEA modality (Before group).  
Setting 
 The setting was the labor and delivery unit at a midwestern critical access hospital. The 
number of deliveries per year over the past five years varied from 55 in 2013 to 80 in 2018.  
Sample 
 The sample included all labor patients with term singleton pregnancy who received 
epidural analgesia in the setting during the pre- and post-measurement period. Women were 
excluded from participating if they had any of the following conditions: preeclampsia, 
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gestational diabetes, intrauterine growth restriction, fetal birth defects or chromosomal 
abnormalities, known placental pathology, and/or poorly controlled systemic disease, and 
patients who delivered less than two hours after the epidural pump was started.   
Project Mission, Vision, and Objectives 
The mission of this project was to provide labor epidural analgesia services of the highest 
quality to give mothers the best possible childbirth experience. The vision of the project was to 
become leaders in providing innovative anesthesia care for mothers and their families that is 
patient-centered, evidence-driven, and of the highest quality and safety. 
The objectives of this project are outlined here: 
Objective 1: The primary researcher collected and analyzed the following data from the 
existing practice of CEI with PCEA modality of labor epidural analgesia including: 
• patient characteristics/demographics (patient age, weight, height, body mass index 
[BMI], ethnicity, race, physical status classification, comorbidities, prenatal 
medications);  
• obstetric data (parity, gestational age, labor type [spontaneous versus induced], 
oxytocin administration, fetal presentation, presence of fetal distress/bradycardia, 
Apgar scores, mode of delivery [vaginal, instrumental, cesarean], length of stages 1 
and 2 of labor, estimated blood loss, perineal tear or episiotomy);  
• cervical dilation at request for epidural; 
• VAS, VNPS, or VRS pain score at time of epidural request; 
• outcome measures (analgesia quality, local anesthetic utilization, motor blockade);  
• maternal satisfaction survey (completed within 48 hours of delivery); 
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• detailed narrative of any untoward epidural complications (e.g., high block level, 
unilateral block, “hot spot,,” catheter migration, hypotension requiring intervention, 
pruritis requiring intervention, nausea/vomiting requiring intervention, etc.). 
This information was gathered from review of patient medical records and review of 
epidural pump history for 10 patients prior to implementation of the practice protocol for PIEB 
with PCEA. Data were logged in a spreadsheet with patient information de-identified and 
securely saved on a computer within the hospital’s network.  
Objective 2: The primary researcher, in collaboration with the research committee, 
developed a practice protocol for implementation of PIEB with PCEA for labor epidural 
analgesia following complete synthesis of the literature. Part of the protocol development 
included consultation with a product representative for instructions on setting up pre-
programmed pump settings for the Sapphire epidural pump currently used at the clinical 
site.  
Objective 3: The primary researcher, along with the multidisciplinary team, developed an 
educational plan about protocol implementation for the CRNAs performing epidural 
analgesia, including an in-service and quick reference guide (QRG). An informational in-
service about the practice changes was originally planned for CRNAs, nursing staff, 
physicians, and pharmacists. A short evaluation was developed to assess participants’ 
understanding of the materials.  
Objective 4: The primary researcher originally planned to collect and analyze the 
following data following implementation of the PIEB with PCEA practice protocol:  
• patient characteristics/demographics (patient age, weight, height, BMI, ethnicity, 
race, ASA status, comorbidities, and prenatal medications);  
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• obstetric data (parity, gestational age, presence of singleton or multiple, labor type 
[spontaneous versus induced], oxytocin administration, fetal presentation, presence of 
fetal distress/bradycardia, Apgar scores, mode of delivery [vaginal, instrumental, 
cesarean], length of stages 1 and 2 of labor, estimated blood loss, and perineal tear or 
episiotomy);  
• cervical dilation at request for epidural; 
• VAS, VNPS, or VRS pain score at time of epidural request; 
• outcome measures (analgesia quality, local anesthetic utilization, and motor 
blockade);  
• maternal satisfaction survey (completed within 48 hours of delivery); 
• detailed narrative of any untoward epidural complications (e.g., high block level, 
unilateral block, “hot spot,” catheter migration, hypotension requiring intervention, 
pruritis requiring intervention, nausea/vomiting requiring intervention, etc.). 
This information was to be gathered from review of patient health records, review of 
epidural pump history, and survey data for at least 10 patients following implementation of the 
practice protocol for PIEB with PCEA. It was planned for data to be logged in a spreadsheet with 
patient information de-identified and securely saved on a computer within the hospital’s 
network.  
Objective 5: The primary researcher originally planned to evaluate the practice protocol 
using data analysis to determine clinical and statistical significance. Process measures 





Key components of this DNP scholarly project included: (a) submission of the University 
of Northern Colorado Institutional Review Board (IRB) application; (b) assembly of a 
multidisciplinary team, including a pharmacist, obstetric provider, labor and delivery registered 
nurse, and quality improvement specialist; (c) development of an evidence-based practice 
protocol for PIEB with PCEA for labor analgesia based on an integrated literature review; (d) 
formation of a staff training plan and QRGs; (e) collection and statistical analysis of pre-
implementation data to include at least 10 patients in the before group; (f) implementation of an 
evidence-based practice protocol for PIEB with PCEA for labor analgesia; (g) collection and 
statistical analysis of post-implementation data to include at least 10 patients in the after group; 
(h) evaluation of structure measures, process measures, outcome measures, and balancing 
measures; and (i) future dissemination of the DNP project results. Because this DNP scholarly 
project was to develop, implement, and evaluate a practice protocol, submission of the IRB 
application sought approval to collect and analyze data from the pre-intervention (before) group, 
implement the protocol, collect and analyzed data from the post-intervention (after) group, and 
evaluate outcomes. Application for IRB approval was submitted following presentation of the 
DNP scholarly project proposal by the primary researcher and approval from the project 
committee. Staff education materials were developed concurrently as the practice protocol was 
created, with the goal of a establishing a comprehensive training plan prior to protocol 
implementation. Collection and statistical analysis of pre-implementation commenced following 
review by the IRB and determination that the project was exempt from further review (Appendix 





 Several instruments were used to measure the outcomes of this DNP project. These 
instruments are described here.  
 Analgesia quality was examined in this study. Several measures indexed quality of 
analgesia, including: (a) patient completion of a VAS, VNPS, or VRS for pain; (b) PCEA 
given:attempted doses gathered from epidural pump history; (c) time to first PCEA use from 
epidural pump history; (d) time to first CRNA intervention (manual bolus of additional epidural 
medication, adjustments in pump settings, or manipulation of the epidural catheter) as 
documented in medical record or epidural pump history as applicable; and (e) number of top-up 
doses delivered by manual bolus as documented in medical records.  
Local anesthetic utilization was analyzed. Data were gathered from review of epidural 
pump history and review of the anesthesia record. In the unlikely event of different local 
anesthetic medications used, the local anesthetic was converted to ropivacaine equivalents as 
previously described by George et al. (2013).  
This DNP project also studied motor blockade. Bromage scores were used as retrieved 
from the participants’ electronic medical records, with motor blockade defined as Bromage score 
of > 1.  
Finally, outcomes were measured by the Maternal Satisfaction Survey. This survey is 
included in Appendix B.  
Analysis 
Data Analysis Procedures  
Descriptive statistics were used for patient characteristics/demographics, obstetric data, 
cervical dilation at request for epidural, pain scores at time of request for epidural, and outcome 
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measures (analgesia quality, motor blockade, and local anesthetic utilization) for the pre-
implementation (before) group. The same data descriptive statistics analysis procedure for the 
post-implementation (after) group was planned, but not completed due to inability to implement 
the protocol as discussed above. Comparison of outcome measures between the before and after 
groups using the Mann-Whitney U test were originally planned, but was not able to be 
completed.  
 Descriptive statistics were used for maternal satisfaction scores from the 5-point Likert 
scale questionnaire. Comparison of individual survey question mean scores between the pre-
implementation group and the post-implementation group using the Mann-Whitney U test were 
originally planned, but not able to be completed.  
Duration of the Project 
 The project was slated for completion upon data collection from a total of 20 patients, 10 
from the pre-implementation group and 10 from the post-implementation group. In the event that 
data on 20 patients was not collected, the plan was to extend the data collection timeline; 
however, the timeline was not able to be extended because the protocol implementation date was 
indeterminate due to the COVID-19 pandemic. 
Ethical Considerations 
 Application for the University of Northern Colorado Institutional Review Board (IRB) 
approval was submitted prior to initiating the DNP project. The AANA Standards of Care for 
professional practice and the “Analgesia and Anesthesia for the Obstetric Patient Practice 
Guidelines” were followed. All participants were protected by the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA), thus protecting the privacy of patients’ health 
information. Information collected was evaluated as aggregate data with potential patient 
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identifiers omitted. Patient confidentiality was assured by coding the participants using 
individual numerical identification. The data were stored electronically and only accessible by 
the primary researcher with password-protected access. The risks associated with participating in 
this project are no different than the risks of receiving the standard labor epidural care. Informed 
consent from each subject was obtained by the CRNA utilizing the clinical site’s existing 











RESULTS AND DATA ANALYSIS 
 
 
This chapter presents the results and data analysis of the DNP project. Each project 
objective is examined and the study questions analyzed. Pre-implementation data analysis from 
the before group is presented using descriptive statistics.  
Objective 1: Data Analysis of Current Practice 
Data from 10 before patients who were representative of the current practice were 
collected. These data were analyzed using descriptive statistics as follows. 
Description of the Before Sample 
Pre-implementation data from a convenience sample of 10 patients in the before group 
were collected and analyzed using descriptive statistics. Patient characteristics and obstetric data 





Characteristics of Patients in the Before Group (N = 10) 







Weight (kg) 87.0 (12.8) 
 
 
Height (cm) 163.6 (5.7) 
 
 
BMI (kg/m2) 32.6 (4.3) 
 
 
Race   
    White  10 (100) 
    Black  0 (0) 
    Asian  0 (0) 
    American Indian  0 (0) 
    Native Hawaiian  0 (0) 
    Other  0 (0) 
   
Ethnicity   
    Hispanic  0 (0) 
    Not Hispanic  10 (100) 
 
Physical Status   
    ASA I  1 (10) 
    ASA II  8 (80) 
    ASA III  1 (10) 
    ASA IV  0 (0) 
    ASA V  0 (0) 
 
Presence of Comorbidities? 
  
    Yes  7 (70) 
    No  3 (30) 







Obstetric Data of Patients in the Before Group (N = 10) 
Characteristic M (SD) Mdn (IQR) n (%) 
Gestational age (weeks) 39.6 (1.1)   
 
Gravidity    
    1   5 (50) 
    2   2 (2) 
    >/= 3   3 (30) 
 
Parity    
    0   5 (50) 
    1   3 (30) 
    2   2 (20) 
    >/= 3   0 (0) 
 
Duration 1st stage of labor (min)  561.0 (408.5, 941.25)  
 
Duration 2nd stage of labor (min)  37 (14.25, 77.0) 
 
 
Oxytocin administration?    
    Yes   6 (60) 
    No   3 (30) 
 
Fetal presentation    
    Vertex   10 (100) 
    Breach   0 (0) 
    Shoulder/transverse   0 (0) 
    Face   0 (0) 
    Brow   0 (0) 
 
Labor type    
   Spontaneous   7 (70) 
   Induced   3 (30) 
 
Presence of fetal distress/bradycardia?    
    Yes   2 (20) 
    No   6 (60) 
 
Apgar 1 minute  8.5 (7.75, 9.0)  
Apgar 5 minute  9.0 (9.0, 9.0)  





Table 2 (continued) 
Characteristic M (SD) Mdn (IQR) n (%) 
 
Mode of delivery 
   
    Vaginal   9 (90) 
    Instrumental (vacuum-assist, forceps)   1 (10) 
    Cesarean   0 (0) 
 
EBL (ml) 455.0 (86.4)   
Perineal repair?     
    Yes   6 (60) 
    No   4 (40) 
 
Note. EBL = estimated blood loss; IQR = interquartile range; M = mean; Mdn = median; ml = milliliters; 
min = minute; SD = standard deviation. 
 
Description of Variables 
Analgesia quality was evaluated using VAS, VNPS, or VRS pain score at time of 
epidural request, 30 minutes after epidural placement, and hourly thereafter until delivery (Table 
3). The mean pain score on a 0-10 scale at the time of epidural request was 7.8 (SD = 1.7). The 
mean post-epidural maximum score was 2.9 (SD = 2.6). The mean post-epidural minimum score 
was 0.9 (SD = 0.9). Eighty percent of patients required at least one PCEA bolus with the mean 
time to first PCEA use 101.5 minutes (SD = 79.9). The ratio of PCEA attempts:given had a 
median of 1 (0.5, 1). One of 10 patients required an adjustment of the pump settings. No patients 
required manual top off boluses by the CRNA or manipulation of the epidural catheter. One of 





Quality of Analgesia in the Before Group (N = 10) 
Characteristic M (SD) Mdn (IQR or range) n (%) 
Cervical dilation at time of request  4.0 (IQR 2.0, 5.25) 
 
 
Pain score at time of request 7.8 (1.7) 
 
  
Pre-epidural MAX 7.1 (2.8) 
 
  
Post-epidural MAX 2.9 (2.6) 
 
  
Post-epidural MIN 0.9 (0.9) 
 
  
Patients requiring PCEA boluses   8 (80) 
 
PCEA attempted  2.5 (IQR 0.75, 4.0) 
 
 
PCEA given  2.0 (IQR 0.75, 3.25) 
 
 
PCEA attempted/given ratio,   1 (range 0.5, 1) 
 
 
Time to 1st PCEA use (min) 101.5 (79.9)  
 
 
Note. IQR = interquartile range; M = mean; Mdn = median; min = minute; PCEA = patient controlled 
epidural analgesia; SD = standard deviation. 
 
Motor blockade was evaluated using the Bromage score 30 minutes after epidural 
placement, and hourly thereafter until delivery (Table 4). The mean post-epidural maximum 
Bromage score was 1.6 (SD = 0.9). Motor blockade, as defined as a Bromage score of >1, was 
documented in 3 out of 10 patients in the before group. Overall compliance with Bromage score 
documentation was poor, with all 10 records missing at least one data point, and two records 





Motor Blockade of Patients in the Before Group (N = 8) 
Characteristic M (SD) n (%) 
 




Post-epidural MAX Bromage Score 1.6 (0.9)  
 
Note. M = mean; SD = standard deviation. 
Local anesthetic utilization was evaluated by calculating hourly and total local anesthetic 
consumption in ropivacaine equivalents (Table 5). Hourly and total fentanyl consumption was 
also collected. The mean hourly ropivacaine utilization was 23.4 mg (SD = 7.4). The median 
total ropivacaine utilization was 92.1 mg (IQR = 54.2, 153.6). The mean hourly fentanyl 
utilization was 23.4 μg (SD = 7.4), and the median total fentanyl utilization was 93.8 μg (IQR = 
56.7, 153.6). Median total epidural pump time in minutes was 225.5 (IQR = 103.5, 529.5).  
Table 5 
Local Anesthetic/Opioid Utilization of Patients in the Before Group (N = 10) 
Characteristic M (SD) Mdn (IQR) 
LA utilization (mg RE)   
    Average hourly 23.4 (7.4)  
    Total LA utilization (mg RE)  92.1 (54.2, 153.6) 
 
Opioid utilization (μg FE)   
    Average hourly 23.4 (7.4)  
    Total fentanyl utilization (μg FE)  93.8 (56.7, 153.6) 
 
Total pump time (min)  225.5 (103.5, 529.5) 
 
Note. FE = fentanyl μg equivalents; IQR = interquartile range; LA = local anesthetic; M = 




Maternal satisfaction was surveyed using a Likert scale tool adapted from Clivatti et al. 
(2013). The survey response rate was 80% (Table 6). 
Table 6 






































I felt NO pain from the time I had my 
epidural until I started pushing. 
 
25.0 37.5 25.0 12.5 0.0 8 
I felt NO pain when I was pushing.  
 
62.5 25.0 12.5 0.0 0.0 8 
The pain medication received through 
labor was enough. 
 
87.5 12.5 0.0 0.0 0.0 8 
The numbness in my legs bothered 
me. 
 
0.0 12.5 12.5 62.5 12.5 8 
The itchiness from the epidural 
medication bothered me.  
 
0.0 0.0 37.5 37.5 25.0 8 
The shivering from the epidural 
medication bothered me.  
 
0.0 50.0 12.5 25.0 12.5 8 
I could not push well due to the 
epidural medication.  
 
0.0 0.0 0.0 50.0 50.0 8 
Overall, my epidural worked well.  
 
62.5 37.5 0.0 0.0 0.0 8 
I would want to receive pain relief 
with an epidural again if I had 
another baby.  
75.0 25.0 0.0 0.0 0.0 8 
*Some parturients did not complete one or more questions.  
Despite the small sample size, minor and temporary untoward epidural complications 
occurred. Patients in the before group required intravenous ephedrine for hypotension after 
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epidural placement (n = 2) or intravenous medications for pruritis (n = 1). There was a unilateral 
block that corrected with positioning the patient on her side and administering a manual bolus of 
local anesthetic through the epidural catheter (n = 1). No other complications were reported. 
Duration of stages 1 and 2 of labor, mode of delivery, prevalence of perineal repair, Apgar 
scores, and presence of fetal distress/bradycardia are presented in Table 2. 
Objective 2: Evidence Evaluation and Protocol  
Development 
An evidence-based clinical practice protocol for PIEB at a critical access hospital was 
developed utilizing a hybrid approach to Stetler’s model for research utilization and the JHNEBP 
model. The integrative review process detailed by Stetler et al. (1998) was used as a guideline for 
performing a utilization-focused critique of the literature, which ultimately led to the 
development of practice recommendations. For the purpose of this scholarly project, the clinical 
practice protocol represented a cohesive compilation of practice recommendations from the 
integrative review. The integrative review incorporated the following steps:  
1. Form an integrative review group. 
2. Outline the problem and review process. 
3. Select and evaluate applicable studies, and synthesize findings. 
4. Develop recommendations based on synthesis. 
5. Disseminate recommendations to the integrative review group for approval.  
Members of the integrative review committee were recruited from the pool of key 
interdisciplinary stakeholders. An OB nurse, an OB physician, the pharmacy manager, the OB 
nursing manager, a nursing informatics specialist, the hospital’s risk manager (who is the Chief 
Nursing Officer), and the primary researcher (who is a CRNA) comprised the seven-member 
integrative review committee. The primary researcher was responsible for outlining the problem 
36 
 
and the review process used to select, evaluate, and synthesize evidence from applicable studies. 
Practice recommendations based on synthesis were disseminated to the integrative review 
committee for feedback and approval. The purpose of the integrated review was synthesis of 
research on PIEB for labor analgesia with the goal of development of a clinical practice protocol 
for a critical access hospital. 
The JHNEBP’s Research Evidence Appraisal Tool was utilized to evaluate the evidence. 
Each piece of evidence was appraised for evidence level and quality rating by the primary 
researcher, then collated into an evidence summary table from the JHNEBP toolkit as a concise 
reference for the integrative review committee. Next, the evidence was synthesized using the 
JHNEBP Synthesis Process and Recommendations Tool. The evidence included multiple studies 
of JHNEBP Level I and Level II evidence; in fact, 16 of the 22 studies included in the synthesis 
were Level I evidence, and 3 were Level II evidence. The overall quality rating for each level of 
evidence was determined. Based on the evidence synthesis, there was a solid indication for 
practice change as indicated by strong, compelling evidence and consistent results among the 
studies. Recommendations in the form of a clinical practice protocol were put forth for review by 
the integrative review committee, and, with minor changes based on feedback from the 
committee, the clinical practice protocol was finalized for implementation. See appendix D for 
Clinical Practice Protocol for Programmed Intermittent Epidural Bolus (PIEB) for Labor 
Analgesia. 
Real-world applicability of the Stetler and JHNEBP models for evidence-based protocol 
development proved to be challenging at a critical access hospital. The recruitment pool was 
limited, and scheduling conflicts posed barriers to interactive discussion. Electronic mail became 
the primary means of communication with members of the integrative review committee. The 
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response rate among several members was poor or nonexistent, despite follow-up reminder 
notifications and in-person requests to respond to e-mails. Input and feedback from the OB 
nurse, pharmacy manager, and CRNA members were largely employed to finalize the protocol. 
This lack of engagement within the committee limited the multidisciplinary validity and 
applicability of the clinical practice protocol. Nonetheless, a clinical practice protocol was 
developed to meet the objective set forth as a part of this DNP scholarly project.  
Objective 3: Translation of the Evidence 
Determination of Fit, Feasibility,  
and Appropriateness to  
Current Practice 
In addition to the external evidence appraisal and synthesis conducted to develop the 
clinical practice protocol, internal data were examined in anticipation of translation of the 
evidence into clinical practice. It was determined that identifying change champions within the 
already formed integrative review committee would be apropos. The change champions were led 
by the primary researcher, who acted as the project leader. In keeping with Stetler’s model and 
the JHNEBP model, fit, feasibility, and current practice were examined.  
Fit 
 For ease of implementation of the new protocol, the clinical site’s existing labor epidural 
policy was used as a template to compose the new evidence-based clinical practice protocol for 
PIEB. The document was then directed through appropriate administrative channels in keeping 
with the clinical site’s formal process for approving new or updated guidelines, policies, and 






 Feasibility of implementing the substantiated findings was considered by the change 
champions, including assessment of risks, resources, and readiness. Details regarding these 
assessments follow. 
 Risks. The potential risks of implementing the protocol included concerns about 
providing adequate analgesia in view of effectively reducing the concentration of the current 
epidural infusion from 0.2% to 0.1% ropivacaine, despite this not being substantiated by the 
body of evidence. Current practice within the anesthesia practice for providing manual boluses 
for breakthrough pain varied. Common practice was to deliver a clinical bolus via the epidural 
pump of 5-10 ml of 0.2% ropivacaine with fentanyl 2 μg/ml or manually bolus 5-10 ml 0.25% 
bupivacaine with or without fentanyl 50-100 μg. The PIEB clinical practice protocol dictated 
treatment of breakthrough pain refractory to two PCEA boluses with the administration of 0.2% 
ropivacaine in 5 ml incremental doses every 10 minutes (up to a maximum of 20 ml) until 
analgesia is satisfactory. Fentanyl 50 μg may be added if pain score is greater than 3/10 after 10 
ml of 0.2% ropivacaine. Research evidence did not explicitly support this recommendation; 
however, several of the study protocols utilized similar or lower concentration bolus regimens 
for breakthrough pain (Capogna et al., 2011; Delgado et al., 2018; Ferrer et al., 2017; Fettes et 
al., 2006; Leo et al., 2010; McKenzie et al., 2016; Nunes et al., 2016; Patkar et al., 2015; Sia et 
al., 2013, 2007; Wong et al., 2011, 2006).   
Theoretical safety concerns, namely high block and catheter migration into the 
subarachnoid space, were voiced. There were no indications in the literature of an additional risk 
with PIEB versus CEI to date, although PIEB safety concerns may become evident as use 
becomes more widespread.  
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Lastly, there was a perceived risk of delivery of stacked PCEA boluses with PIEB (e.g., a 
programmed bolus delivered in a short time interval from PCEA bolus). Several studies 
discussed algorithms designed as part of the study protocol or programmed into the respective 
epidural pump (Delgado et al., 2018; Leo et al., 2010; Rodriguez-Campoo et al., 2018; Sia et al., 
2013, 2007; Tien et al., 2016). The QCore Medical Sapphire epidural infusion pump used at the 
clinical site allowed for programming of a lockout time between boluses, regardless of PCEA or 
PIEB. For the purpose of this project, the lockout time was set to 15 minutes. If a PIEB was 
delivered, the next available PCEA bolus would occur after 15 minutes. Similarly, if a PCEA 
bolus was delivered within 15 minutes prior to when a programmed intermittent bolus was due to 
be delivered, it would be delayed until 15 minutes had elapsed between boluses. 
 Resources. The resources required for implementation of the project were minimal due 
to the longstanding provision of labor epidural services already in place at the clinical site. There 
were no anticipated impacts to capital and operational costs. The clinical site owns two epidural 
pumps with advanced technology capable of PIEB programming. Additionally, the clinical site 
provides annual in-services for the nursing staff, during which one of the CRNAs lectures about 
a topic related to obstetric anesthesia. The focus of this year’s lecture was aimed at educating the 
staff on the PIEB clinical practice protocol; however, the annual in-services were postponed until 
further notice due to COVID-19 concerns.  
 Readiness. The change champion team included the hospital’s risk manager, who was 
also the Chief Nursing Officer. A culture of leadership support of evidence-based practice is an 
important factor in engaging stakeholders at all levels and a potential strength for 
implementation of the PIEB protocol. Unfortunately, the clinical site had minimal exposure to 
formal evidence-based research utilization in clinical practice, which posed a potential barrier to 
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implementation. Critical access hospitals encounter several unique challenges when compared to 
larger medical organizations, one of which is lack of educational preparation regarding the 
process of research utilization. In an informal inquiry, it was found that the overall attitude 
toward implementing an evidence-based project was positive, with a few individuals expressing 
lack of value of evidence-based research utilization compared to longstanding dogma and 
anecdotal clinical data. These perceived barriers posed real concerns about protocol 
noncompliance that may result in skewed project outcomes.  
Current Practice 
 The need for change was substantiated by the available evidence. Analysis of the before 
data from the existing labor epidural practice described above served as the basis for comparison 
of outcome measures following implementation of the PIEB clinical practice protocol.  
Action Plan 
A pragmatic approach to developing an action plan was deemed necessary for successful 
implementation of the PIEB clinical protocol. It was decided that the recommendations from the 
appraisal and synthesis of evidence did not provide all the details required for a complete 
protocol. This was an expected finding and, thus, the clinical site’s extant labor epidural policy 
was reviewed and used as a template to compose the new evidence-based clinical practice 
protocol for PIEB. Outdated policy items were updated with the integrative review team’s 
recommendations from the appraisal and synthesis of the evidence. Package dissemination was 
anticipated with direct instrumental use in the form of protocol roll-out to include nursing staff 
in-service during the clinical site’s annual training sessions and quick reference guides. The 
protocol was approved for implementation by the clinical site following appropriate 
administrative channels.  
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Unfortunately, the COVID-19 pandemic presented as an unforeseen barrier to 
implementation as staff furloughs impeded the delivery of staff education and training. For this 
reason, the clinical site personnel made the decision to delay protocol implementation until a 
new plan for annual staff in-services is developed by the clinical site’s nursing education 
department. Once a definitive implementation date is set by the multidisciplinary team, the 
epidural pumps will be reprogrammed to allow for the protocol’s PIEB pump settings, the 
electronic labor epidural order sets will be deployed, the pharmacy department will ensure 
availability of the protocol epidural infusion bags, staff education will be completed, and QRGs 
will be disseminated. 
Objective 4: Evaluation of the Practice Change 
 The evaluation plan for this evidence-based project comprises formative and summative 
evaluation, including structure, process, outcome, and balancing measures. This evaluation plan 
was developed by incorporating Donabedian’s (2005) three components of structure, process, 




 Structural elements of import for this evidence-based project included resources available 
to support successful protocol implementation. These resources included epidural pumps with 
advanced technology, competent staff members, staff education resources, and administrative 
support. The COVID-19 pandemic resulted in delay of staff educational in-services and 
reallocation of committee members to serve the more immediate needs associated with COVID-




 During data collection from the before group of 10 patients who received continuous 
epidural infusions, it was determined that documentation in the electronic medical record 
deviated from the requirements set forth in the clinical site’s existing labor epidural policy. For 
example, the duration of the first and second stages of labor was not easily discernible in the 
electronic medical record. Additional findings include the lack of hourly pain scores for the 
duration of the epidural infusion, as well as complete omissions of Bromage scores. Data from 
the epidural pumps proved to be most reliable in terms of completeness due to the 
comprehensive pump history. For these reasons, refinements in the staff educational 
presentations were made to draw greater focus to the nursing assessment and documentation 
requirements for patients with labor epidurals. Additionally, a template for the CRNAs to use in 




Primary outcome measures were analgesia quality, motor blockade, and local anesthetic 
utilization. Secondary outcome measures were neonatal outcomes, maternal outcomes, and mode 
of delivery (Table 2). Data from the before group were collected and analyzed for comparison to 
the post-implementation data from the after group. 
 Analgesia Quality. Several measures indexed quality of analgesia. These measures 
included VAS, VNPS, or VRS for pain, PCEA given/attempted doses gathered from epidural 
pump history, time to first PCEA use from epidural pump history, time to first CRNA 
intervention (manual bolus of additional epidural medication, adjustments in pump settings, or 
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manipulation of the epidural catheter) as documented in medical record or epidural pump history 
as applicable, and number of top-up doses delivered by manual bolus as documented in medical 
record (Table 3). 
 Motor Blockade. Bromage score was retrieved from the patients’ electronic medical 
records, with motor blockade defined as Bromage score of >1. Motor blockade was assessed 30 
minutes after epidural placement and hourly thereafter (Table 4). 
 Local Anesthetic Utilization. Data were gathered from review of epidural pump history 
and review of the anesthesia record. In the unlikely event of different local anesthetic 
medications used, the local anesthetic was converted to ropivacaine equivalents as previously 
described by George et al. (2013). Several measures were used to evaluate local anesthetic 
utilization, including hourly and total local anesthetic utilization, and hourly and total fentanyl 
utilization (Table 5). 
Balancing Measures 
Balancing measures were assessed to evaluate if improvements gained from the PIEB 
protocol implementation would negatively impact another area as a result of the practice change. 
Those measures included maternal satisfaction and any untoward epidural complications. 
Analyses of Study Questions 
 This DNP project aimed to answer three PICOT questions related to the efficacy of PIEB 
with PCEA settings for labor analgesia compared to CEI with PCEA on quality of analgesia, 
motor blockade, and local anesthetic utilization when implemented in healthy laboring women in 
a critical access hospital. Due to unforeseen circumstances related to the COVID-19 pandemic, 
the PIEB protocol was not implemented and, thus, the study questions remain unanswered. 
Preliminary data were collected and analyzed, an evidence-based protocol was developed, and 
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translation and evaluation plans were established for future use at such time as the available 















 This chapter includes a summary of the scholarly project, including conclusions, 
limitations, and recommendations for future practice. To close, a reflection on how this scholarly 
project met the outcomes of the American Association of Colleges of Nursing’s (AACN) The 
Essentials of Doctoral Education in Advanced Nursing Practice (2006) using the EC as PIE 
(enhance, culmination, partnerships, implements, and evaluation) criteria (Waldrop et al., 2014) 
is imparted.   
Conclusions 
The purpose of this DNP scholarly project was to develop, implement, and evaluate an 
evidence-based clinical practice protocol for PIEB for labor analgesia for multidisciplinary use 
that focused on improving labor epidural analgesia outcomes. The PIEB technique for labor 
epidural analgesia has been shown in numerous studies to demonstrate advantages over 
traditional approaches to epidural analgesia, namely improved quality of analgesia, decreased 
local anesthetic consumption, and improved maternal satisfaction. A number of promising 
studies were the impetus for developing a clinical practice protocol for translation of the 
evidence to clinical practice in a critical access hospital. A PIEB clinical practice protocol was 
developed from extensive review of the research and an integrative review process by a 
multidisciplinary team to ascertain a cohesive compilation of practice recommendations 
applicable to the target population of healthy laboring women in a critical access hospital 
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requesting labor epidural analgesia. Stetler’s model for research utilization was combined with 
the JHNEBP model and was the theoretical frameworks guiding this project.  
Healthy laboring women with term singleton pregnancies who received epidural 
analgesia and met the inclusion criteria were included in the pre-intervention sample (n = 10). 
The sample size was determined using historical data on the number of newborn deliveries per 
year at the clinical site and the feasible duration of the project. Data from a convenience sample 
of 10 patients in the before group was collected and analyzed using descriptive statistics. All of 
the sample participants were White, non-Hispanic, and English speaking. The mean age of 
participants was 26 years old. Majority of participants were categorized as ASA physical status 
II, and 70% of the sample had comorbidities documented in their electronic medical record. The 
average gestational age was 39.6 weeks, with 50% of participants being primigravida. 
Participants in the before group consumed an average hourly ropivacaine equivalent of 23.4 mg 
with a median epidural pump infusion time of 225.5 minutes. Eighty percent of participants 
required PCEA boluses and the mean time to first PCEA use was 101.5 minutes after epidural 
placement. The mean maximum pain score following epidural placement was 2.9 on a 0-10 
scale. The incidence of motor blockade defined as a Bromage score >1 was 37.5%; however, 
interpretation of these findings is cautioned due to the overall insufficiency of documentation of 
Bromage scores.  
Collection and statistical analysis of post-implementation data of a convenience sample 
of 10 patients was originally planned following protocol implementation, but not completed due 
to the COVID-19 pandemic. Though project completion as originally planned was curtailed due 
to the COVID-19 pandemic, the multidisciplinary team achieved protocol finalization, pre-
implementation data collection and analysis, development of a staff training plan, logistical 
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organization of epidural pump reprogramming, and plans for post-implementation data 
collection. The data collection procedure for the post-implementation group was originally 
planned to mirror that of the pre-implementation group, but not achieved due to inability to 
implement the protocol as a result of the COVID-19 pandemic.  
Although the project execution did not unfold as originally planned, it did present an 
opportunity for dynamic evaluation of adherence to the clinical site’s existing epidural policy. 
This allowed for refinement of staff training resources directed not only at PIEB protocol 
competency, but also at standards of care for patients with labor epidurals, including focused 
assessment and documentation requirements. The clinical site provides annual in-services for the 
nursing staff, during which one of the CRNAs lectures was to address a topic related to obstetric 
anesthesia. Package dissemination of the PIEB clinical practice protocol was anticipated with 
roll-out to include nursing staff in-service during the clinical site’s annual training sessions and 
quick reference guides; however, the COVID-19 pandemic presented unforeseen barriers to 
implementation as staff furloughs impeded the delivery of staff education and training. For this 
reason, the clinical site made the decision to delay protocol implementation until a new plan for 
annual staff in-services could be developed by the clinical site’s nursing education department.  
Additionally, analysis of a short evaluation of staff understanding of educational 
materials to determine readiness for implementation was originally planned, but not completed 
due to the decision from the clinical site’s administration to postpone the annual in-services for 
the nursing staff. Analysis comparing pre- and post-implementation data to determine clinical 
and statistical significance was also originally planned, but unable to be achieved due to the 
project being cut short by the COVID-19 pandemic. Process measures were to be evaluated to 
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determine degree of fidelity to the protocol following implementation in addition to evaluation of 
balancing measures to determine impact, but, again, not completed.  
A dissemination plan for knowledge gained from this DNP scholarly project was to 
include a poster presentation at the clinical site displayed in the labor and delivery unit, but will 
instead be replaced by a poster presentation with project tasks completed to date and future steps. 
Consideration for collaborative engagement with hospital administration, nursing, and advanced 
practice providers/physicians will be forthcoming in the form of presentation of the DNP project 
outcomes at various staff meetings. 
Limitations 
 There were several limitations to this project. During the planning stages of the scholarly 
project, a sample size of 10 was considered achievable within the project timeframe due to the 
clinical site’s past annual newborn delivery rate. Upon commencement of data collection for the 
before group, it was determined that reaching a sample size of 10 was going to take longer than 
originally anticipated. It is postulated that seasonal fluctuations in the local birth rate may have 
been a factor.  
Inadequate documentation in the electronic medical record was also a limitation to data 
collection. The clinical site had recently transitioned to a new electronic medical record system, 
and while data collection for the before group occurred after training and implementation of the 
new system, clinical documentation in the electronic medical record was scant compared to 
previous paper-based clinical documentation. It is likely that mastery of the functionality of the 
new electronic medical record system among the users had not yet occurred. Another 
consideration was that nursing staff were not familiar with the clinical site’s existing labor 
epidural policy, which led to non-compliance with assessment and documentation requirements.  
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 Critical access facilities face unique challenges and often lag behind in regard to the 
implementation of evidence-based practice. The barriers to research utilization in a rural setting 
were underestimated and presented limitations even in the first steps of the project plan. 
Assembling an integrative review team to develop a multidisciplinary clinical practice protocol 
was challenging due to lack of time, lack of availability, and lack of confidence in judging the 
quality of research. Stetler et al. (1998) advised that recruiting individuals knowledgeable about 
research utilization for the integrative review group permits translation of the research for the 
group in a user-friendly fashion, which, unfortunately, was not easily attainable in a small rural 
healthcare setting. Lack of time and other work commitments were often cited as reasons for not 
being able to fulfil the tasks of the integrative review process. An asynchronous schedule was 
utilized to allow members to review the available literature and develop recommendations. The 
integrative review process was largely unilateral due to a lack of engagement by the members of 
the group. This limited the multidisciplinary validity and applicability of the clinical practice 
protocol.  
 Lastly, the COVID-19 pandemic was a substantial limitation to this DNP scholarly 
project. While great strides were made to develop a PIEB clinical practice protocol and 
implement it in clinical practice, the actual implementation remained theoretical due to obstacles 
posed by the COVID-19 pandemic. The clinical site continues to work toward overcoming the 
setbacks resulting from the COVID-19 pandemic and is hopeful that 2021 is a year of rebuilding 
and growth. As of early 2021, the clinical site has no definitive plans on when they will be able 
to resume the annual nursing in-services, which is a determining factor for providing the 




Recommendations for Future Practice 
 Considering that this DNP scholarly project was cut short as a repercussion of the 
COVID-19 pandemic, the recommendations for future practice include completion of the 
objectives as originally projected. This would include translating the clinical practice protocol 
for PIEB into practice. Package dissemination remains appropriate with direct instrumental use 
in the form of protocol roll-out to include nursing staff in-service during the clinical site’s annual 
training sessions upon their resumption and quick reference guides. This would include 
assessment of knowledge of the learning objectives.  
 Prior to implementation of the PIEB clinical practice protocol, reassessment of the 
resources and readiness of the clinical site may need to be conducted to ensure as smooth an 
implementation as possible. Following implementation of the PIEB clinical practice protocol, 
collection of data from the after group to include a convenience sample of at least 10 patients is 
recommended. Descriptive statistical analysis would mirror that of the before group analysis. At 
this point, inferential statistical analysis using the Mann-Whitney U test would be completed to 
compare outcome measures and maternal satisfaction scores between the pre- and post-
implementation groups.  
 In situ evaluation of the practice change could then be carried out to include both 
formative and summative evaluation. Donabedian’s (2005) model remains applicable in 
evaluating structure, process, outcome, and balancing measures for this scholarly project. The 
PICOT questions put forth could then be answered to determine the effectiveness of PIEB with 
PCEA settings for labor analgesia compared to CEI with PCEA on quality of analgesia, the 




Reflections on Executing a Successful Doctor of  
Nursing Practice Project 
The EC as PIE acronym (enhance, culmination, partnerships, implements, and 
evaluation) put forth by Waldrop and colleagues (2014) represents five criteria that must be met 
in order to display the rigor and excellence necessary to meet the outcomes of the AACN 
essentials and execute a successful DNP project. A reflection on how this DNP scholarly project 
met the EC as PIE criteria is outlined in the following section.  
• E = Enhance health outcomes, practice outcomes, or health care policy. This DNP 
scholarly project involved evaluating a current practice for labor epidural analgesia in 
a critical access hospital. The project focused on enhancing labor analgesia outcomes 
by providing stakeholders with an evidence-based clinical practice protocol used to 
implement the practice change from CEI to PIEB for labor analgesia. Implementing 
clinical protocols in the provision of labor epidural analgesia has the potential to 
improve outcomes by helping practitioners provide the best evidence-based care to 
their patients.  
• C = Reflect a culmination of practice inquiry. A culmination of practice inquiry was 
evidenced by both a focused and broad understanding of how to enact change in the 
clinical setting. An extensive literature review and synthesis was utilized to develop a 
multidisciplinary protocol for PIEB for labor analgesia. Theoretical frameworks, 
including the Stetler model for research utilization and the JHNEBP model, were 
used to evaluate the literature and use knowledge gained to effect change in the 
clinical setting.  
• Partnerships = Require engagement in partnerships. Several key partnerships were 
evident during the execution of this DNP scholarly project. The project involved 
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recruitment of and coordination with key stakeholders to form an integrative review 
group in order to engage in meaningful discourse during the development of the 
clinical practice protocol. Additionally, a multidisciplinary team with stakeholders 
from diverse backgrounds was responsible for the development of staff education 
about the clinical practice protocol. Although collaborative partnerships were 
challenging to coordinate during this DNP project, their importance should not be 
discounted as change would not be possible without the involvement of the entire 
team in the process.  
• I = Implement/apply/translate evidence into practice. Evidence was gathered through 
the literature review process and synthesized into practice recommendations. The 
recommendations were then disseminated to the integrative review committee for 
feedback and approval. A PIEB clinical practice protocol was developed to meet the 
needs of the target population, and a recommended translation plan was formulated.  
• E = Requires evaluation of health care, practice, or policy outcomes. This DNP 
scholarly project included formative and summative evaluation as recommended by 
Stetler (2001). Structure and process measures as described by Donabedian (2005) 
were evaluated to determine the degree to which the clinical site’s infrastructure and 
resources would support the project and how processes of care could be improved to 
support successful translation of the evidence into clinical practice. Summative 
evaluation of outcome and balancing measures has been proposed as a method of 
ongoing evaluation once the clinical practice protocol is implemented. Outcome 
measures specific to this DNP scholarly project examined the effect of implementing 
PIEB for labor analgesia on quality of analgesia, motor blockade, and local anesthetic 
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utilization compared to the current practice of CEI for labor analgesia. This involved 
data collection and analysis from the before group prior to implementation of the 
protocol. Balancing measures include tracking of untoward epidural complications 
and surveying of maternal satisfaction with a 5-point Likert scale questionnaire.  
Summary 
 Delivery of PIEB is a novel modality for providing effective pain relief to laboring 
women. Up until recently, epidural pumps with advanced technology capable of PIEB dosing 
were not readily available. Fortunately, epidural pumps with these capabilities are becoming 
more widespread, and studies on optimal epidural solutions, dosing, and interval timing have 
garnered promising support in favor of PIEB settings. This DNP project sought to develop, 
implement, and evaluate an evidence-based clinical practice protocol for PIEB for labor 
analgesia in a critical access hospital. Due to obstacles encountered as a result of the COVID-19 
pandemic, the project did not come to complete fruition as envisioned. Implementation and 
subsequent evaluation of the PIEB clinical practice protocol was not achieved.  
Despite these obstacles, a multidisciplinary team was able to finalize an evidence-based 
clinical practice protocol for PIEB, collect and analyze pre-implementation data, develop a staff 
training plan, organize the logistical aspects of epidural pump reprogramming, and plan eventual 
protocol implementation and evaluation. Future recommendations include completion of the 
project as originally planned and continued organizational support for implementation of 
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United Hospital District 
Maternal Satisfaction Survey 
 
Please fill in the number that represents how you feel about your epidural 
experience.  
 
The placement of the epidural was comfortable.  
 
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
I felt NO pain from the time I had my epidural until I started pushing.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
I felt NO pain when I was pushing.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
The pain medication received throughout labor was enough.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
The numbness in my legs bothered me.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  











The itchiness from the epidural medication bothered me.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
The shivering from the epidural medication bothered me.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
I could not push well due to the epidural medication.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
Overall, my epidural worked well.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  
Agree           Disagree 
 
I would want to receive pain relief with an epidural again if I had another baby.  
1  2  3  4  5 
Strongly  Agree  Neutral  Disagree  Strongly  








Thank you for completing this survey. Your feedback will help us continue to 
provide exceptional care.  
 
 
































Clinical Practice Protocol for Programmed Intermittent 
Epidural Bolus (PIEB) for Labor Analgesia 
 
Laraine Klunder, APRN, CRNA 
Nurse Anesthetist, United Hospital District 
 
INTRODUCTION 
This protocol is intended for use by certified registered nurse anesthetists (CRNAs), obstetrical 
registered nurses (OB RNs), and obstetrical providers for healthy women, regardless of parity 
status, with singleton term pregnancy in active labor requesting epidural analgesia at United 
Hospital District (Blue Earth, Minnesota). Active labor includes spontaneous or induced labor 
during which contractions are regular and result in dilation of the cervix.  
 
This protocol does not apply to women presenting in preterm labor (< 38 weeks’ gestation), or 
those with multiple pregnancy, preeclampsia, gestational diabetes, intrauterine growth 
restriction, fetal birth defects or chromosomal abnormalities, known placental pathology, 
and/or poorly controlled systemic disease. Refer to UHD Epidural Policy on J drive.  
 
The premise of the provision of epidural analgesia for labor is adequate pain relief 
while supporting maternal and neonatal outcomes. Programmed intermittent epidural bolus 
(PIEB) modality of analgesia has been shown to improve quality of analgesia, decrease local 
anesthetic consumption, minimize motor blockade, and improve maternal 
satisfaction compared to continuous epidural infusion (CEI) mode of delivery (Sng et al., 2018). 
Other potential benefits of a PIEB modality may include reduced cesarean delivery rate, 
reduced instrumental vaginal delivery rate, less provider rescue boluses, and shorter second 




The CRNA is responsible for placing and managing the epidural, which includes: 
• Obtaining consent for epidural catheter placement and labor analgesia 
• Inserting the epidural catheter 
• Administering test dose and bolus injections 
• Topping off catheters as needed 
• Entering orders for nursing care 
 
The OB RN* is responsible for maintaining the epidural infusion, which includes:  
• Monitoring vital signs, fetal heart tones (FHTs), sensory block level, degree of motor 
block, and sedation level 
• Monitoring for side effects 





• Stopping infusion for emergencies or after delivery 
• Discontinuing epidural catheter with appropriate documentation after delivery 
*The OB RN is required to complete competency for maintaining epidural infusions, 
including the infusion pump and removal of epidural catheters.  
 
EQUIPMENT 
• Sapphire epidural pump 
• Epidural infusion bags premixed by Pharmacy or manufacturer 
• Yellow epidural tubing 
 
PROCEDURE/RESPONSIBILITES 
I. ANESTHESIA PROVIDER 
A. The Department of Anesthesia assumes the responsibility for the epidural infusions and 
side effects, or complications associated with this technique. The CRNA will: 
1. Select appropriate patient based on relative and absolute contraindications as 
follows: 
a. Absolute contraindications to the placement of an epidural catheter 
include: 
• Patient refusal 
• Intrinsic coagulation disorder or pharmacologically anticoagulated 
• Active skin infection at the catheter insertion site 
• Increased intracranial pressure 
b. Relative contraindications to the placement of an epidural catheter include: 
• Pre-existing neurological disease 
• Allergies to local anesthetics and opioids 
• Hypovolemia 
• Central nervous system disease 
• Chronic low back pain 
c. Assess pharmacologic anticoagulation of the patient as this affects both the 
placement and removal of epidural catheters. Follow American Society of 
Regional Anesthesia (ASRA) guidelines.  
2. Obtain consent, including risks, benefits, and alternatives to treatment.  
3. Perform and document a pre-anesthesia evaluation, including pre-epidural pain 
score.  
a. Pain score will be assessed on a 0-10 scale as visual analog scale (VAS), 
visual numeric pain score (VNPS), or verbal rating scale (VRS) 
4. Participate in “Time Out” procedure.  
5. Insert epidural catheter.  
a. Epidural analgesia will be initiated with the patient in sitting position at the 
L3-4 or L4-5 interspace. The epidural space will be identified using loss of 
resistance to saline technique with a 17-gauge Tuohy epidural needle, bevel 
cephalad. A 20-gauge closed-end, multi-orifice epidural catheter will be 




6. Perform test dose to confirm placement in the epidural space.  
a. A test dose of 3 mL of 1.5% lidocaine with 1:200,000 epinephrine will be 
administered.  
7. Administer loading dose to obtain appropriate sensory block.  
a. After verification of a negative test, an additional 2 mL of 1.5% lidocaine 
with 1:200,000 epinephrine and a loading dose of up to 10 mL of 0.1% 
ropivacaine with 2mcg/ml fentanyl will be administered.  
b. If bilateral sensory block at the T10 level is not achieved 30 minutes after 
the loading dose and the patient is still in pain, an additional 5 mL of 0.1% 
ropivacaine with 2mcg/ml fentanyl will be administered.  
c. If bilateral sensory block at the T10 level is not achieved after 45 minutes 
and the patient is still in pain, the epidural catheter will be re-sited, and the 
patient withdrawn from the protocol. 
8. After loading dose, assess and document pain score, sensory level, and motor 
blockade in procedure note. 
a. Pain score is measured on a 0-10 scale as VAS, VNPS, or VRS 
b. Sensory level is measured by cold perception bilaterally with dermatome 
levels as follows:  
• S1: Back of calf 
• L1: Pelvic/iliac crest 
• T10: Umbilicus 
• T8: Lower ribs/between umbilicus and xyphoid process 
• T6: Xyphoid process 
• T4: Nipple line 
c.  Motor blockade is measured using Bromage as follows: 
• 1 = Free movement of legs and feet 
• 2 = Just able to flex knees with free movement of feet 
• 3 = Unable to flex knees, but with free movement of feet 
• 4 = Unable to move legs or feet 
9. Initiate the epidural infusion.  
a. Epidural infusion bag: 0.1% ropivacaine with 2mcg/ml fentanyl 100ml 
b. Pump settings will be as follows:  
QCore Medical Sapphire epidural infusion pump 
PIEB 10 mL every 40 minutes starting 30 minutes after loading dose 
PCEA 5 mL, lockout 15 minutes (max 4 PCEA boluses per hour) 
10. Troubleshoot the epidural catheter for any possible complications (e.g., 
unsatisfactory sensory block, disconnected or leaking catheter) 
a. If the patient has breakthrough pain at any time during labor for which two 
consecutive PCEA doses within 30 minutes are ineffective, administer 
manual bolus as follows: 
• 0.2% ropivacaine in 5 ml incremental doses every 10 minutes (up 




• Fentanyl 50mcg if pain score greater than or equal to 3/10 after 
10ml of 0.2% ropivacaine.  
• If inadequate analgesia persists after 20ml of manual bolus and 
fentanyl 50mcg, it is considered failed epidural and the patient is 
excluded from the protocol. Epidural re-siting recommended with 
infusion per departmental policy.  
11. Electronically enter order set UHD ANE OB PIEB FOR LABOR AND DELIVERY - 
CRNA.  
12. Change epidural dressing as necessary.  
13. In the event of cesarean section, epidural catheter may be used per anesthesia 
provider’s clinical judgment.  
14. Review and approve orders for anticoagulation when ordered by other providers 
when alerted by Pharmacy or Nursing for patients currently with epidural 
catheters or recently discontinued epidural catheters.  
15. Enter an order as to when to initiate anticoagulant therapy after catheter 
removal.  
16. Be immediately available via telephone for consultation.  
 
II. OB PROVIDER 
A. May request consultation from the Anesthesia Department 
B. Manage continuing analgesia after discontinuation of epidural infusion.  
C. Permit nursing to implement orders from UHD ANE OB PIEB FOR LABOR AND 
DELIVERY – CRNA order set and contact CRNA with any questions regarding orders. 
 
III. PHARMACY 
A. Review and provide the ordered epidural formulation of 0.1% ropivacaine with 
2mcg/ml fentanyl.  
B. Verify that medications are preservative free.  
C. Verify that the patient has no recorded allergy to the ordered medications.  
D. Ensure that Intralipid and resuscitation drugs are available on each unit on which 
epidural infusions are infused. 
E. Alert the ordering, CRNA, and nursing when anticoagulant drugs are ordered for 
patients receiving epidural medications prior to dispensing anticoagulants.  
F. Verify the label on the epidural bag states “preservative free” and for “epidural use”.  
 
IV. NURSING 
A. Conduct a patient assessment prior to the procedure, including, but not limited to, 
history, vital signs, pain, FHTs, and labor progress. 
B. Obtain intravenous (IV) access and administer IV fluid bolus as directed by the CRNA. 
C. Retrieve epidural infusion bag and emergency OB tray from Pyxis to be at bedside.  
D. Assist the CRNA with placement of the epidural catheter as required, including 
witnessing consent and conducting “Time Out”.  
E. Review and verify epidural pump settings, epidural medication in the bag to the drug 




1.  Initial programming of the pump 
2.  Changes in pump settings or medications as ordered by the CRNA 
3.  Replacement of empty epidural infusion bag with new epidural infusion bag.  
F. Adhere to UHD ANE OB PIEB FOR LABOR AND DELIVERY – CRNA order set for 
management of breakthrough pain and side effects. Enforce strict bedrest and place 
Foley catheter as ordered.  
G. Reinforce and document patient education in the electronic health record.  
1.  Patient education is a shared responsibility between Nursing, Anesthesia, and OB 
provider. Topics include:  
a. Use of PCEA button. The family is educated that only the patient is 
allowed to push the button.  
b. Pain rating scale 
c. Bolus interval and safety parameters of PCEA 
d. Adverse side effects and what patient should report to RN 
e. Other interventions for pain control, both pharmacologic and 
nonpharmacologic.  
f. Patients are cautioned to be careful when turning and to wait for 
assistance while catheter is in place.  
g. Ambulation is not permitted during epidural analgesia.  
H. Assessment and Monitoring 
1. Nursing will monitor vital signs, FHTs, tocodynametry, pain score, sensory level, 
and motor blockade.   
a.  Vital signs will be assessed and documented as follows:   
• NIBP, HR, RR, and SpO2 Q5min x3, Q15min x3, then hourly 
b. FHTs and tocodynametry will be assessed and documented per nursing 
policy. 
c. Pain score is measured on a 0-10 scale as VAS, VNPS, or VRS, and 
documented 30 minutes after loading dose, then hourly for duration of 
epidural analgesia. 
d. Sensory level is measured by cold perception bilaterally with 
dermatome levels, and documented Q5min x3, Q15min x3, then hourly 
for duration of epidural analgesia, as follows:  
• S1: Back of calf 
• L1: Pelvic/iliac crest 
• T10: Umbilicus 
• T8: Lower ribs/between umbilicus and xyphoid process 
• T6: Xyphoid process 
• T4: Nipple line 
e. Motor blockade is measured using Bromage, and documented 30 
minutes after loading dose, then hourly for duration of epidural 
analgesia, as follows: 
• 1 = Free movement of legs and feet 




• 3 = Unable to flex knees, but with free movement of feet 
• 4 = Unable to move legs or feet 
I. Documentation 
1. The OB RN will document vital signs in the electronic health record (EHR) during 
placement of the epidural catheter, including NIBP and HR Q5min and continuous 
SpO2. FHTs and tocodynametry will be documented per nursing policy.  
2. Post-epidural documentation for the OB RN is outlined in bullet point H.1. 
3. Additional OB RN documentation includes, but is not limited to:  
a. Co-signature with another RN or CRNA in the medication 
administration record (MAR) upon initiation of the epidural infusion 
verifying medication and pump settings match the order, 
b. Epidural catheter site assessment, 
c. Cumulative shift totals, 
d. Presence of side effects,  
e. Patient education, and 
f. Discontinuation of the epidural catheter upon delivery.  
4. The CRNA will document a pre-procedure evaluation and procedure note in the 
EHR. The dot phrase .UHDLABORPIEB will be used in the procedure note.  
J. Fluid, Catheter, and Dressing Change Issues 
1. Epidural infusion bag is changed every 48 hours 
2. Epidural pump tubing is changed every 72 hours 
3. In the event of accidental disconnection of the epidural catheter from the 
connector, DO NOT RECONNECT THE CATHETER. Wrap the patient end in a sterile 
dressing and notify anesthesia provider.  
4. Dressing changes are to be done by the anesthesia provider as needed. If the 
dressing is no longer intact, reinforce the edges with tape and notify the 
anesthesia provider.  
5. Assess catheter insertion site every shift. Notify anesthesia provider of site pain, 
excessive back pain, redness, bleeding, edema, or drainage at catheter site.  
K. Nursing Management for Side Effects and Complications 
1.  In case of emergency, the RN will stop the infusion, call for help, and notify 
anesthesia immediately. Emergencies include, but are not limited to:  
a. Cardiac or respiratory arrest, or RR < 10 
b. Decreased level of consciousness 
• If patient is somnolent or has minimal to no response to physical 
stimulation, administer naloxone 0.1mg IV push while awaiting 
physician and/or CRNA; may repeat every 5 minutes until 
adequate ventilation and alertness is achieved without significant 
pain.  
c. Signs of local anesthetic toxicity (e.g., confusion, tinnitus, circumoral 
tingling/numbness, blurred vision, dizziness, metallic taste, altered 
speech, or seizures) 
d. Sensory level above the T6 (xyphoid process) 




f. Signs of epidural hematoma or abscess, such as new significant 
backache or new or increasing lower extremity weakness 
g. Signs and symptoms of infection at the catheter site, such as fever, 
pain, warmth, drainage, or redness 
h. Epidural catheter disconnection 
2. Conditions requiring notification of anesthesia provider 
a. Inadequate pain relief after assessment by the OB RN to include: 
• Pain score 
• PCEA utilization (if patient has not been using PCEA, encourage 
use for 30 minutes prior to calling CRNA) 
• Consider repositioning patient 
• Assessment for bladder distension 
• Assessment of cervical dilation and progress of labor 
b. Unrelieved nausea and vomiting 
c. Unrelieved itching 
d. Decrease in SBP less than 90mmHg or drop of >20% of baseline SBP  
• Administer ephedrine or phenylephrine per UHD ANE OB PIEB 
FOR LABOR AND DELIVERY - CRNA order set 
e. Decreased level of consciousness or change in mental status 
f. Anticoagulation orders (except subcutaneous heparin, NSAIDS, or low 
dose aspirin unless other anticoagulants or antiplatelets are also 
ordered) 
L. Discontinuation of the epidural catheter 
1. Policy 
a. RNs must complete competency packet in order to become qualified to 
remove epidural catheters. 
b. There must be an order in the HER to remove epidural catheter. 
c. If there is any concern about safe epidural removal, the RN will notify 
the anesthesia provider.  
2. Stopping the infusion 
a. The epidural infusion should be discontinued at the time of delivery 
unless extensive repair or other complication is anticipated. 
b. If a tubal ligation is planned, consult anesthesia provider for an order to 
retain or remove epidural catheter. 
c. To stop the infusion press STOP, then press OFF. 
3. Removal of the epidural catheter 
a. Explain the procedure to the patient. 
b. Don nonsterile gloves.  
c. Assist the patient into a sitting or lateral position with the back flexed.  
d. Disconnect the epidural catheter from the infusion tubing.  
e. Remove the tape and sterile dressing from the patient’s back starting at 




f. Grasp the catheter at the skin and pull with a constant gentle pressure 
at a 90-degree angle to the skin. If any resistance if felt, STOP, place a 
sterile dressing over the site and call anesthesia provider immediately. 
Never forcefully remove an epidural catheter.  
g. Assess the insertion site for bleeding, bruising, swelling, redness, or 
discharge.  
h. Inspect the catheter to ensure the tip in intact.  
i. Document catheter removal in the EHR, noting that the tip was intact 
upon removal.  
j. Waste the remaining epidural medication per Pharmacy Medication 
Management Policy on J drive.  
k. Clean the epidural pump per current infection control guidelines.   
